The peptoids were synthesized on an ABI 433 peptide synthesizer using the submonomer method [25] on Rink amide MBHA resin. Briefly, bromoacetic acid activated by diisopropylcarbodiimide is used to form a bromoacetylated intermediate on a terminal secondary amine group. Bromine is then substituted with the desired primary amine through an SN2 displacement, to build the peptoid chain. The synthesized peptoids were cleaved from the resin using trifluoroacetic-acid:triisopropylsilane:water (95:2.5:2.5, v:v:v) for 10 minutes. The peptoids were purified by reversed-phase HPLC using a C18 column and a linear acetonitrile/water (0.1% trifluoroacetic acid) gradient of 5%–95% acetonitrile over 45 minutes. Final purity was greater than 98% and correct molecular identity was verified using electrospray ion mass spectrometry. The control peptides were synthesized using solid phase Fmoc chemistry, purified to purity > 95% using reversed phase HPLC, and were analyzed by mass spectrometry by GenScript (Piscataway, NJ, USA).
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.